ADT, androgen deprivation therapy; ICI, immune checkpoint inhibitor; VEGFR-TKI, vascular endothelial growth factor receptor tyrosine kinase inhibitor.
Treatment-induced cardiovascular toxicity is linked to ADT, VEGFR-TKIs, ICIs, and chemotherapy. We propose the new discipline of uro-cardio-oncology to address the relationship between cardiovascular disease and urological cancers. ADT, androgen deprivation therapy; ICI, immune checkpoint inhibitor; VEGFR-TKI, vascular endothelial growth factor receptor tyrosine kinase inhibitor.